Forskolin Modulates the Inhibitory Effect of C-Type Natriuretic Peptide on Hypoxia-Induced Atrial Dynamics and Hypoxia Inducible Factor 1 Alpha Activity

Chengming Guan,Yanan Jia,Chaochao Bian,Bo Zhang,Dazhi Ding,Xun Cui
DOI: https://doi.org/10.4236/jbm.2017.51001
2017-01-01
Journal of Biosciences and Medicines
Abstract:Our study investigated effects of C-type natriuretic peptide (CNP) on atrial dynamics and hypoxia inducible factor 1 alpha (HIF-1α) activity in perfused beating rat atria, under hypoxic conditions.Hypoxia significantly increased the levels of HIF-1α, concomitant with decreased trial dynamics.CNP (0.1 µmol/L) further decreased atrial dynamics under hypoxia and suppressed hypoxia-induced stimulation of HIF-1α expression.An adenylylcyclase (AC) activator, forskolin (0.1 µmol/L), significantly up-regulated atrial phosphodiesterase subtype 3A (PDE 3A) protein without affecting hypoxia-induced dynamics.In the presence of forskolin, the inhibitory effects of CNP on hypoxiainduced atrial dynamics and HIF-1α levels were significantly attenuated.Forskolin also prevented hypoxia-induced downregulation of PDE3A protein.These findings suggested that CNP inhibited atrial dynamics and HIF-1α activity in the isolated perfused beating rat atria under hypoxic conditions.Furthermore, both effects were modulated by the AC activator forskolin, through activation of CNP-PDE 3A signaling.
What problem does this paper attempt to address?